14-day Premium Trial Subscription Try For FreeTry Free
RSI low/high Values: [ 25 - 80 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of NWRN.SW
Powered by GPT-4
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

A very strong day for Newron Pharmaceuticals S.p.A. stock price on Friday
(Updated on May 03, 2024)

Buy or Hold candidate since Apr 29, 2024 Gain 19.11% PDF

The Newron Pharmaceuticals S.p.A. stock price gained 9.51% on the last trading day (Friday, 3rd May 2024), rising from 8.31 Fr to 9.10 Fr. It has now gained 5 days in a row. It will be exciting to see whether it manages to continue gaining or take a minor break for the next few days. During the last trading day the stock fluctuated 9.79% from a day low at 8.38 Fr to a day high of 9.20 Fr. The price has risen in 7 of the last 10 days and is up by 36.23% over the past 2 weeks. Volume has increased on the last day along with the price, which is a positive technical sign, and, in total, 42 thousand more shares were traded than the day before. In total, 206 thousand shares were bought and sold for approximately 1.88 Fr million.

The stockhas broken the wide and falling short-term trend up. Firstly a slower falling rate is indicated, but this may very well be an early signal of a trend shift. On the reaction, there will be support on the roof of the current trend broken, which is 8.06 Fr, a level that may pose a second chance to hit a runner. According to fan-theory 9.64 Fr will be the next possible trend-top level and thereby pose a resistance level that may not be broken at the first attempt.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

NWRN.SW Signals & Forecast

The Newron Pharmaceuticals S.p.A. stock holds buy signals from both short and long-term Moving Averages giving a positive forecast for the stock. Also, there is a general buy signal from the relation between the two signals where the short-term average is above the long-term average. On corrections down, there will be some support from the lines at 7.75 Fr and 7.63 Fr. A breakdown below any of these levels will issue sell signals. A buy signal was issued from a pivot bottom point on Thursday, April 18, 2024, and so far it has risen 36.23%. Further rise is indicated until a new top pivot has been found. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Volume is rising along with the price. This is considered to be a good technical signal.

Support, Risk & Stop-loss for Newron Pharmaceuticals S.p.A. stock

Newron Pharmaceuticals S.p.A. finds support from accumulated volume at 9.02 Fr and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock may move much during the day (volatility) and with a large prediction interval from the Bollinger Band this stock is considered to be "high risk". During the last day, the stock moved 0.82 Fr between high and low, or 9.79%. For the last week, the stock has had daily average volatility of 12.17%.

Our recommended stop-loss: 8.77 Fr (-3.68%) (This stock has high daily movements and this gives high risk. There is a buy signal from a pivot bottom found 10 days ago.)

Trading Expectations (NWRN.SW) For The Upcoming Trading Day Of Monday 6th

For the upcoming trading day on Monday, 6th we expect Newron Pharmaceuticals S.p.A. to open at 8.89 Fr, and during the day (based on 14 day Average True Range), to move between 8.44 Fr and 9.76 Fr, which gives a possible trading interval of +/-0.657 Fr (+/-7.22%) up or down from last closing price. If Newron Pharmaceuticals S.p.A. takes out the full calculated possible swing range there will be an estimated 14.44% move between the lowest and the highest trading price during the day.

With no resistance above and support from accumulated volume @ 9.02 Fr, some 0.0800 Fr (0.88%) from the current price of 9.10 Fr, our system finds the risk reward attractive.

Is Newron Pharmaceuticals S.p.A. stock A Buy?

Newron Pharmaceuticals S.p.A. holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Buy to a Hold/Accumulate candidate.

Current score: 0.000 Hold/Accumulate Downgraded

Zero in score indicates that our system is expecting high volatility and risk for the following trading day. Given the latest developments, we cannot determine the next direction as it may go both ways.

Predicted Opening Price for Newron Pharmaceuticals S.p.A. of Monday, May 6, 2024

Fair opening price May 6, 2024 Current price
8.89 Fr ( 2.27%) 9.10 Fr

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for NWRN.SW

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 9.71 6.74 %
R2 9.40 3.30 %
R1 9.21 1.17 %
Current price: 9.10
Support S1 8.58 -5.71 %
S2 8.39 -7.84 %
S3 8.07 -11.28 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 0 .
R2 0 .
R1 0 .
Current price 9.10
Support S1 9.02 -0.88%
S2 8.21 -9.78%
S3 7.82 -14.07%

FAQ

What is the symbol for Newron Pharmaceuticals S.p.A. Stock and on which exchange is it traded?
The symbol for Newron Pharmaceuticals S.p.A. is NWRN.SW and it is traded on the SIX (SIX Swiss Exchange).

Should I buy or sell Newron Pharmaceuticals S.p.A. Stock?
Newron Pharmaceuticals S.p.A. holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Buy to a Hold/Accumulate candidate.

How to buy Newron Pharmaceuticals S.p.A. Stock?
Newron Pharmaceuticals S.p.A. Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Newron Pharmaceuticals S.p.A. Stock.

What's the current price of Newron Pharmaceuticals S.p.A. Stock?
As of the end of day on the May 03, 2024, the price of an Newron Pharmaceuticals S.p.A. (NWRN.SW) share was 9.10 Fr.

What is the 52-week high and low for Newron Pharmaceuticals S.p.A. Stock?
The 52-week high for Newron Pharmaceuticals S.p.A. Stock is 193.10 Fr and the 52-week low is 79.20 Fr.

What is the market capitalization of Newron Pharmaceuticals S.p.A. Stock?
As of the May 03, 2024, the market capitalization of Newron Pharmaceuticals S.p.A. is 169.549M.

When is the next earnings date for Newron Pharmaceuticals S.p.A.?
The upcoming earnings date for Newron Pharmaceuticals S.p.A. is Sep 19, 2024.
Click to get the best stock tips daily for free!

About Newron Pharmaceuticals S.p.A.

Newron Pharmaceuticals S.p.A. Newron Pharmaceuticals S.p.A., a clinical stage biopharmaceutical company, focuses on the research and development of therapies for the treatment of central and peripheral nervous system, and pain in Italy and the United States. The company offers Xadago (safinamide) for the treatment of Parkinson's disease, as well as develops Xadago for the treatment of levodopa induced dyskinesia. It also develops Evenamide for Schizophrenia and treatment resi... NWRN.SW Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT